XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Net revenues
 6 Months Ended
Jun. 27, 2021
Revenue from Contract with Customer [Abstract]  
Net revenues Net revenuesWe primarily generate revenue from the sale of medical devices including single use disposable devices and, to a lesser extent, reusable devices, instruments and capital equipment. Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; this occurs upon the transfer of control of the products. Generally, transfer of control to the customer occurs at the point in time when our products are shipped from the manufacturing or distribution facility. For our Original Equipment and Development Services ("OEM") segment, most revenue is recognized over time because the OEM segment generates revenue from the sale of custom products that have no alternative use and we have an enforceable right to payment to the extent that performance has been completed. We market and sell products through our direct sales force and distributors to customers within the following end markets: (1) hospitals and healthcare providers; (2) other medical device manufacturers; and (3) home care providers, which comprised 89%, 9% and 2% of consolidated net revenues, respectively, for the six months ended June 27, 2021. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. With respect to the custom products sold in the OEM segment, revenue is measured using the units produced output method. Payment is generally due 30 days from the date of invoice.
The following table disaggregates revenue by global product category for the three and six months ended June 27, 2021 and June 28, 2020.
Three Months EndedSix Months Ended
June 27, 2021June 28, 2020June 27, 2021June 28, 2020
Vascular access$167,739 $164,958 $331,712 $315,214 
Anesthesia95,426 64,867 180,283 140,569 
Interventional112,082 82,594 208,255 182,525 
Surgical98,185 67,275 178,571 142,707 
Interventional urology92,243 40,094 165,607 114,286 
OEM60,956 55,832 114,445 119,219 
Other (1)
86,842 91,414 168,525 183,156 
Net revenues (2)
$713,473 $567,034 $1,347,398 $1,197,676 
(1)Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products).
(2)The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.